Anti-Corruption Regs In China Should Be Warning Sign For Companies
This article was originally published in PharmAsia News
Executive Summary
The Chinese government's focus on corruption means device companies doing business there must redouble compliance efforts, according to Australia medical device lobbyist Anne Trimmer
You may also be interested in...
China’s Top Pharma Firms Prosper; Private Innovators Likely To Lead Sector
Small companies struggle to advance in new, stricter regulatory environment.
China’s Top Pharma Firms Prosper; Private Innovators Likely To Lead Sector
Small companies struggle to advance in new, stricter regulatory environment.
China’s Top Pharma Firms Prosper; Private Innovators Likely To Lead Sector
BEIJING - China's strengthening regulation of the pharmaceutical sector and expanding national health insurance coverage, along with rising incomes, are all triggering a boom for the country's leading drug makers, according to a new study of the sector